Style | Citing Format |
---|---|
MLA | Shamsigooshki E, Parsapoor A, Moosavi S. "Ethical Challenges in Conducting Research in Low and Middle Income Setting During Public Health Emergencies: A Qualitative Evidence of a Covid-19 Pandemic: The Experience of Iran." BMC Medical Ethics, vol. 26, no. 1, 2025, pp. -. |
APA | Shamsigooshki E, Parsapoor A, Moosavi S (2025). Ethical Challenges in Conducting Research in Low and Middle Income Setting During Public Health Emergencies: A Qualitative Evidence of a Covid-19 Pandemic: The Experience of Iran. BMC Medical Ethics, 26(1), -. |
Chicago | Shamsigooshki E, Parsapoor A, Moosavi S. "Ethical Challenges in Conducting Research in Low and Middle Income Setting During Public Health Emergencies: A Qualitative Evidence of a Covid-19 Pandemic: The Experience of Iran." BMC Medical Ethics 26, no. 1 (2025): -. |
Harvard | Shamsigooshki E, Parsapoor A, Moosavi S (2025) 'Ethical Challenges in Conducting Research in Low and Middle Income Setting During Public Health Emergencies: A Qualitative Evidence of a Covid-19 Pandemic: The Experience of Iran', BMC Medical Ethics, 26(1), pp. -. |
Vancouver | Shamsigooshki E, Parsapoor A, Moosavi S. Ethical Challenges in Conducting Research in Low and Middle Income Setting During Public Health Emergencies: A Qualitative Evidence of a Covid-19 Pandemic: The Experience of Iran. BMC Medical Ethics. 2025;26(1):-. |
BibTex | @article{ author = {Shamsigooshki E and Parsapoor A and Moosavi S}, title = {Ethical Challenges in Conducting Research in Low and Middle Income Setting During Public Health Emergencies: A Qualitative Evidence of a Covid-19 Pandemic: The Experience of Iran}, journal = {BMC Medical Ethics}, volume = {26}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Shamsigooshki E AU - Parsapoor A AU - Moosavi S TI - Ethical Challenges in Conducting Research in Low and Middle Income Setting During Public Health Emergencies: A Qualitative Evidence of a Covid-19 Pandemic: The Experience of Iran JO - BMC Medical Ethics VL - 26 IS - 1 SP - EP - PY - 2025 ER - |